Fabulous Fundraisers!
Read more about our amazing MIA fundraisers, including some big adventures planned!
Parliamentary Friends launch
An inspiring day at Parliament House in Canberra for the launch of ‘Parliamentary Friends of Melanoma and Skin Cancer Awareness’.
Stop glamourising tanning
Read how you can help us STOP THE GLAMOURISATION OF TANNING.
Thank you, Community Fundraisers!
A shout out to all our wonderful community fundraisers, who have supported MIA in the last two months.
Personalised Immunotherapy Platform (PIP)
PIP is a tool developed by MIA to ensure advanced melanoma patients receive effective treatment the first time, based on their own genetics and tumour biology.
Join in Melanoma March 2023 and support Aussies impacted by melanoma
Melanoma March events across the country to fund ground-breaking clinical trial into psychological stresses experienced by advanced melanoma patients.
ABC-X Clinical Trial
The ABC-X clinical trial seeks to determine if the addition of radiotherapy, to combination immunotherapy, results in improved outcomes for patients with melanoma brain metastases.
A second penicillin moment for cancer treatment
In a world-first, an early phase trial of an mRNA personalised cancer vaccine has shown promising results for preventing melanoma recurrence in patients with resected high-risk melanoma (stage III and IV).
MPA-MIA Melanoma Community Webinar Series 2022
Watch recordings of the 2022 webinar series. Webinars cover Brain Metastases, Immunotherapy & Targeted Therapies, and Detecting Melanoma.
Clarivate announce Highly Cited Researchers 2022 list
Read more about the five MIA researchers named on the Clarivate list of Highly Cited Researchers 2022.